Skip to main content
. 2020 Oct 4;11(23):6902–6915. doi: 10.7150/jca.49532

Table 3.

Application of aptamers in clinical trials

Aptamers Targets Phase References
Macugen VEGF Approved 168
E10030 PDGF Phase III 169
AS1411 Nucleolin Phase II 124
ARC1779 vWF Phase II 170
NU172 Thrombin Phase II 171
NOX-A12 SDF-1 Phase II 172
NOX-E36 MCP-1 Phase II 172
NOX-H94 Hepcidin Phase I 173
ARC1905 Complement component 5 (C5) Phase II 174
REG1 Coagulation factor IXa Phase III 175
ARC19499 Hemophilia Phase I 176